3rd Quarter - Report

CHAMBER HILL STRATEGIES for GLAXOSMITHKLINE, INC.

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Education and importance of various pharmaceutical industry issues, including the Part D prescription drug program; and broad payment reform issues included within P.L. 113-93, Protecting Access to Medicare Act of 2014; and S.1932, Better Care, Lower Cost Act.

LobbyistCovered position, as disclosed
JENNIFER BELL Legislative Assistant, Rep. John Thune (R-SD)
MICHAELA SIMS Legislative Director and Counsel, Sen. Bob Kerrey (D-NE)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1932 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.